BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10676471)

  • 1. Intraventricular injections of tachykinin NK3 receptor agonists affect salt intake. A shift in taste intensity?
    Smith ME; Flynn FW
    Ann N Y Acad Sci; 1999; 897():432-5. PubMed ID: 10676471
    [No Abstract]   [Full Text] [Related]  

  • 2. Lateral ventricular injections of the NK3 agonist senktide affect salt taste-elicited responses.
    Flynn FW; Smith ME
    Peptides; 1998; 19(2):319-24. PubMed ID: 9493864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain tachykinins and the regulation of salt intake.
    Flynn FW
    Ann N Y Acad Sci; 1999; 897():173-81. PubMed ID: 10676446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraventricular injections of tachykinin NK3 receptor agonists suppress the intake of "salty" tastes by sodium deficient rats.
    Flynn FW
    Behav Brain Res; 2006 Jan; 166(1):1-8. PubMed ID: 16154648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of the selective tachykinin NK3 receptor agonist NH2-senktide on intraoral intake and taste reactivity responses elicited by NaCl in sodium-replete rats.
    Polidori C; Pompei P; Ciccocioppo R; de Caro G; Massi M
    Regul Pept; 1996 Oct; 66(1-2):101-4. PubMed ID: 8899901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tachykinin receptor subtype. Central cardiovascular regulation of tachykinin peptides.
    Takano Y; Nagashima A; Hagio T; Nakayama Y; Kamiya H
    Ann N Y Acad Sci; 1991; 632():476-8. PubMed ID: 1719908
    [No Abstract]   [Full Text] [Related]  

  • 7. Central neurokinin 3 receptors increase systemic oxytocin release: interaction with norepinephrine.
    Bealer SL; Flynn FW
    Exp Neurol; 2003 Dec; 184(2):1027-33. PubMed ID: 14769397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tachykinin NK3 receptor agonist blocks sodium deficiency-induced shift in taste reactivity.
    Smith ME; Flynn FW
    Brain Res; 1994 Nov; 665(1):123-6. PubMed ID: 7533632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of intraventricular injections of tachykinin NK1 and NK3 receptor agonists on normal and sham drinking of NaCl by sodium-deficient rats.
    Flynn FW; Smith ME; Bieber SL
    Behav Neurosci; 1999 Aug; 113(4):776-86. PubMed ID: 10495085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurokinin-1, -2 and -3 receptors are candidates for a role in the opiate withdrawal response in guinea-pigs.
    Johnston PA; Chahl LA
    Regul Pept; 1993 Jul; 46(1-2):376-8. PubMed ID: 7692541
    [No Abstract]   [Full Text] [Related]  

  • 11. Application of taste reactivity to study the mechanism of alcohol intake inhibition by the tachykinin aminosenktide.
    Polidori C; Recchi S; Venturi F; Ciccocioppo R; Massi M
    Peptides; 1998; 19(9):1557-64. PubMed ID: 9864063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tachykinin NK(3)receptor involvement in anxiety.
    Ribeiro SJ; Teixeira RM; Calixto JB; De Lima TC
    Neuropeptides; 1999 Apr; 33(2):181-8. PubMed ID: 10657489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraventricular injections of tachykinin NK3 receptor agonist reduce the gain of the baroreflex in unrestrained rats.
    Flynn FW
    Exp Neurol; 2005 May; 193(1):118-24. PubMed ID: 15817270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of NK-1 receptor in central cardiovascular regulation in rats: studies on a novel non-peptide antagonist, CP-96,345, of substance P NK-1 receptor.
    Saigo A; Takano Y; Saito R; Nakayama Y; Honda K; Kamiya H
    Regul Pept; 1993 Jul; 46(1-2):293-6. PubMed ID: 7692520
    [No Abstract]   [Full Text] [Related]  

  • 15. The tachykinin NK3 receptor agonist senktide induces locomotor activity in male Mongolian gerbils.
    Nordquist RE; Durkin S; Jacquet A; Spooren W
    Eur J Pharmacol; 2008 Dec; 600(1-3):87-92. PubMed ID: 18930726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tachykinin NH2-senktide, a selective neurokinin B receptor agonist, is a very potent inhibitor of salt appetite in the rat.
    Massi M; Polidori C; Gentili L; Perfumi M; de Caro G; Maggi CA
    Neurosci Lett; 1988 Oct; 92(3):341-6. PubMed ID: 2462199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride.
    Seeley RJ; Blake K; Rushing PA; Benoit S; Eng J; Woods SC; D'Alessio D
    J Neurosci; 2000 Feb; 20(4):1616-21. PubMed ID: 10662851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of action for reduction of ethanol intake in rats by the tachykinin NK-3 receptor agonist aminosenktide.
    Ciccocioppo R; Panocka I; Polidori C; Froldi R; Angeletti S; Massi M
    Pharmacol Biochem Behav; 1998 Dec; 61(4):459-64. PubMed ID: 9802842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of salt intake in the rat by neurokinin A: comparison with the effect of kassinin.
    Massi M; Epstein AN
    Regul Pept; 1989 Mar; 24(3):233-44. PubMed ID: 2540511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of neurokinin 3 receptors on responses to colorectal distention in the rat: electrophysiological and behavioral studies.
    Julia V; Su X; Buéno L; Gebhart GF
    Gastroenterology; 1999 May; 116(5):1124-31. PubMed ID: 10220504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.